X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options granted weighted average remaining contractual terms. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award other than options forfeitures and expirations in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award other than options outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award other than options vested and expected to vest outstanding number. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award other than options vested outstanding number. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award other than options exercises in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangements by share based payment award other than options grants in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options agregate intrinsic value grants. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|